2-methyl-4,5,6,7-tetrafluorobenzimidazole | 81430-75-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 2-methyl-4,5,6,7-tetrafluorobenzimidazole
• 英文别名: 4,5,6,7-tetrafluoro-2-methyl-1H-benzo[d]imidazole；4,5,6,7-tetrafluoro-2-methyl-1H-benzimidazole
• CAS: 81430-75-3
• 化学式: C₈H₄F₄N₂
• mdl: MFCD00521797
• 分子量: 204.127
• InChiKey: MQJXZZMBIIYRAJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  28.7
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-methyl-4,5,6,7-tetrafluorobenzimidazole 在 sodium hydroxide 作用下， 反应 6.0h， 生成 1-ethyl-2-methyl-3,3,3-trifluoropropyl-4,5,6,7-tetrafluorobenzimidazolium p-toluenesulfonate
  参考文献：
  名称：

  2-甲基-4,5,6,7-四氟苯并咪唑衍生物的花菁染料

  摘要：

  DOI：

  10.1007/bf00507000
• 作为产物：
  描述：

  3,4,5,6-四氟苯-1,2-二胺 在 盐酸 、 氨 作用下， 反应 3.0h， 生成 2-methyl-4,5,6,7-tetrafluorobenzimidazole
  参考文献：
  名称：

  2-甲基-4,5,6,7-四氟苯并咪唑衍生物的花菁染料

  摘要：

  DOI：

  10.1007/bf00507000

文献信息

• [EN] SOMATOSTATIN MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE SOMATOSTATINE ET LEURS UTILISATIONS
  申请人：CRINETICS PHARMACEUTICALS INC

  公开号：WO2019157458A1

  公开（公告）日：2019-08-15

  Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.

  本文描述了一些能够调节生长抑素的化合物，制备这些化合物的方法，包括这些化合物的药物组合物和药物，在治疗需要调节生长抑素活性的疾病、病症或疾病中使用这些化合物的方法。
• COPPER-OXYGEN ADDUCT COMPLEXES
  申请人：Schindler Siegfried

  公开号：US20120016127A1

  公开（公告）日：2012-01-19

  The invention at hand describes Cu-(II)-oxygen adduct complexes, which are stable at room temperature, as well as methods for their production. In this, compounds of the general formula [L-Cu—O—O—Cu-L](BAr 4 ) 2 are concerned. Here, BAr 4 − is a tetraarylborate anion, selected from tetraphenylborate and tetrakis(3,5-trifluoromethyl)phenylborate. L represents a tripodal tetradentate ligand, wherein, each of the four binding sites of the tripodal tetradentate ligand is a nitrogen atom. Each of the three podal ligands is suitable for comprising an aliphatic amine or a nitrogen-containing heteroaromatic compound independently of one another. A bridge of one to four carbon atoms is located between the central nitrogen atom and the nitrogen atom of each of the podal ligands. The Cu-(II)-oxygen adduct complexes according to the present invention are produced, by initially reacting the ligand L with a Cu-(I) salt to [Cu-L]X. Subsequently, the anion X of the Cu-(I) complex [Cu-L]X is replaced with tetraarylborate and the compound [Cu-L]BAr 4 obtained in this way is finally exposed to an oxygen-containing atmosphere. Hereby, [L-Cu—O—O—Cu-L](BAr 4 ) 2 is formed. The Cu-(II)-oxygen adduct complexes are suitable for being used as oxidation catalysts, for example for the oxidation of benzene to phenol or methane to methanol, for the oxidation of hydrogen, aromatic and aliphatic, saturated and unsaturated hydrocarbons, as well as alcohols and amines. Furthermore, detection of the Cu-(II)-oxygen adduct complexes according to the present invention is suitable for being used for the detection of oxygen.

  本发明描述了在室温下稳定的Cu-(II)-氧加合物配合物，以及它们的生产方法。在此，涉及到具有一般式[L-Cu—O—O—Cu-L](BAr4)2的化合物。这里，BAr4−是一种四芳基硼酸盐阴离子，可从四苯基硼酸盐和四(3,5-三氟甲基)苯基硼酸盐中选择。L代表一个三足四齿配体，其中，三足四齿配体的四个结合位点分别是氮原子。每个三足配体适合独立地包括脂肪胺或含氮杂环化合物。在中央氮原子和每个三足配体的氮原子之间有一个由一到四个碳原子组成的桥连接。根据本发明，Cu-(II)-氧加合物配合物是通过首先将配体L与Cu-(I)盐反应形成[Cu-L]X来生产的。随后，Cu-(I)配合物[Cu-L]X的阴离子X被四芳基硼酸盐取代，以此方式获得的化合物[Cu-L]BAr4最终暴露在含氧气氛中。这样，[L-Cu—O—O—Cu-L](BAr4)2就形成了。根据本发明，Cu-(II)-氧加合物配合物适用于用作氧化催化剂，例如用于苯氧化为苯酚或甲烷氧化为甲醇，以及氢氧化、芳香族和脂肪族、饱和和不饱和碳氢化合物、醇类和胺类的氧化。此外，根据本发明，检测Cu-(II)-氧加合物配合物适用于用于检测氧气。
• N-Trihalomethyl derivatives of benzimidazole, benzotriazole and indazole
  作者：Lev M Yagupolskii、Dmitrij V Fedyuk、Kirill I Petko、Valeriya I Troitskaya、Valentina I Rudyk、Vitalij V Rudyuk

  DOI：10.1016/s0022-1139(00)00321-3

  日期：2000.12

  1-Chlorodifluoromethyl- and 1-trifluoromethyl-substituted 2-methylbenzimidazoles and benzotriazoles were obtained by chlorination of the corresponding methyl 1-azoledithiocarboxylates and subsequent fluorination of the resulting 1-trichloromethyl derivatives. The condensation of N-sodium salts of 2-alkylbenzimidazoles and indazole with CF2Br2 was shown to afford the corresponding 1-bromodifluoromethylated

  通过氯化相应的1-唑二硫代羧酸甲酯，然后将所得的1-三氯甲基衍生物氟化，得到1-氯二氟甲基和1-三氟甲基取代的2-甲基苯并咪唑和苯并三唑。显示2-烷基苯并咪唑和吲唑的N-钠盐与CF 2 Br 2的缩合得到相应的1-溴二氟甲基化的化合物。
• Benzimidazole derivatives and their use as protein kinases inhibitors
  申请人：Berdini Valerio

  公开号：US20070135477A1

  公开（公告）日：2007-06-14

  The invention provides compounds of the formula (1): The compounds have activity against cyclin depdenent kinases, glycogen synthase kinase and Auroa kinases and are therefore useful to treat cancer and viral diseases.

  该发明提供了式（1）的化合物： 这些化合物具有对环素依赖性激酶、糖原合成酶激酶和Auroa激酶的活性，因此可用于治疗癌症和病毒性疾病。
• HETEROCYCLIC CETP INHIBITORS
  申请人：Wang Yufeng

  公开号：US20070135467A1

  公开（公告）日：2007-06-14

  Compounds of formula Ia and Ib wherein A, B, C and R 1 are described herein.

  本文描述的是化学式Ia和Ib的化合物，其中A、B、C和R1被定义。